New ultrasound procedure targets deadly lung clots, aims to reduce bleeding risk
NCT ID NCT07452991
Summary
This study is testing a specialized procedure for people with serious, but not immediately life-threatening, lung blood clots (pulmonary embolism). Doctors use a catheter (thin tube) guided by ultrasound to deliver clot-dissolving medicine directly to the clot in the lung. The goal is to see if this targeted approach is safe and effective, especially in reducing the risk of major bleeding that can happen with standard clot-busting drugs given through a vein.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM (PE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Medical Research Center for Cardiology named after academician Yevgeniy Chazov of the Ministry of Health of the Russian Federation
RECRUITINGMoscow, Russia
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.